Gastroenterology Services Limited 05000247 false 2024-01-01 2024-12-31 2024-12-31 The principal activity of the company is gastroenterology services. Digita Accounts Production Advanced 6.30.9574.0 true 05000247 2024-01-01 2024-12-31 05000247 2024-12-31 05000247 core:RetainedEarningsAccumulatedLosses 2024-12-31 05000247 core:ShareCapital 2024-12-31 05000247 core:CurrentFinancialInstruments 2024-12-31 05000247 core:CurrentFinancialInstruments core:WithinOneYear 2024-12-31 05000247 core:KeyManagementPersonnelCloseFamilyMembersEntitiesUnderKeyManagementPersonnelsControl 2024-12-31 05000247 bus:SmallEntities 2024-01-01 2024-12-31 05000247 bus:AuditExemptWithAccountantsReport 2024-01-01 2024-12-31 05000247 bus:FilletedAccounts 2024-01-01 2024-12-31 05000247 bus:SmallCompaniesRegimeForAccounts 2024-01-01 2024-12-31 05000247 bus:RegisteredOffice 2024-01-01 2024-12-31 05000247 bus:CompanySecretaryDirector1 2024-01-01 2024-12-31 05000247 bus:Director1 2024-01-01 2024-12-31 05000247 bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 05000247 core:KeyManagementPersonnel 2024-01-01 2024-12-31 05000247 core:KeyManagementPersonnelCloseFamilyMembersEntitiesUnderKeyManagementPersonnelsControl 2024-01-01 2024-12-31 05000247 countries:EnglandWales 2024-01-01 2024-12-31 05000247 core:KeyManagementPersonnelCloseFamilyMembersEntitiesUnderKeyManagementPersonnelsControl 2023-12-31 05000247 2023-01-01 2023-12-31 05000247 2023-12-31 05000247 core:RetainedEarningsAccumulatedLosses 2023-12-31 05000247 core:ShareCapital 2023-12-31 05000247 core:CurrentFinancialInstruments 2023-12-31 05000247 core:CurrentFinancialInstruments core:WithinOneYear 2023-12-31 05000247 core:KeyManagementPersonnelCloseFamilyMembersEntitiesUnderKeyManagementPersonnelsControl 2023-12-31 05000247 core:KeyManagementPersonnelCloseFamilyMembersEntitiesUnderKeyManagementPersonnelsControl 2023-01-01 2023-12-31 05000247 core:KeyManagementPersonnelCloseFamilyMembersEntitiesUnderKeyManagementPersonnelsControl 2022-12-31 iso4217:GBP xbrli:pure

Registration number: 05000247

Gastroenterology Services Limited
Unaudited Filleted Financial Statements
for the Year Ended 31 December 2024

Pages for filing with Registrar

Gastroenterology Services Limited

Contents

Company Information | 1
Balance Sheet | 2
Notes to the Unaudited Financial Statements | 3 to 6

Gastroenterology Services Limited

Company Information

Directors | Prof D A F Lynch Mrs C B Lynch

Company secretary | Mrs C B Lynch

Registered office | Thomas House Meadowcroft Business Park Pope Lane Whitestake Lancashire PR4 4AZ

Gastroenterology Services Limited

(Registration number: 05000247)
Balance Sheet as at 31 December 2024

| Note | 2024 £ | 2023 £
Current assets |  |  |
Debtors | 4 | 141,471 | 137,756
Cash at bank and in hand |  | 59,617 | 22,771
|  | 201,088 | 160,527
Creditors: Amounts falling due within one year | 5 | (41,978) | (45,715)
Net assets |  | 159,110 | 114,812
Capital and reserves |  |  |
Called up share capital |  | 20 | 20
Retained earnings |  | 159,090 | 114,792
Shareholders' funds |  | 159,110 | 114,812

For the financial year ending 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

• | The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
• | The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 16 September 2025 and signed on its behalf by:

......................................... Prof D A F Lynch Director

Gastroenterology Services Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2024

1 | General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Thomas House
Meadowcroft Business Park
Pope Lane
Whitestake
Lancashire
PR4 4AZ

The principal place of business is:
Pale Farm Barn
Moss Lane
Chipping
Preston
Lancashire
PR3 2TR

These financial statements were authorised for issue by the Board on 16 September 2025.

2 | Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

The financial statements are prepared in Sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

Gastroenterology Services Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2024 (continued)

2 | Accounting policies (continued)

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the provision services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.
The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for services performed in the ordinary course of business.
Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.
Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Gastroenterology Services Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2024 (continued)

2 | Accounting policies (continued)

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

Financial instruments

Classification
The Company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments. Financial instruments are recognised in the Company’s statement of financial position when the company becomes party to the contractual provisions of the instrument.
Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and liability simultaneously.
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. As equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.
Equity instruments issued by the company are recorded at the proceeds received, net of direct issue costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

3 | Staff numbers

The average number of persons employed by the company (including directors) during the year, was 2 (2023 - 2).

4 | Debtors

Current | 2024 £ | 2023 £
Trade debtors | 19,777 | 15,375
Prepayments | 207 | 200
Other debtors | 121,487 | 122,181
| 141,471 | 137,756

Gastroenterology Services Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2024 (continued)

4 | Debtors (continued)

Details of non-current trade and other debtors

£21,024 (2023 -£21,024) of Recoverable tax is classified as non current.

5 | Creditors

Creditors: amounts falling due within one year

| 2024 £ | 2023 £
Taxation and social security | 27,587 | 42,349
Accruals and deferred income | 14,391 | 3,366
| 41,978 | 45,715

6 | Related party transactions

Loans to related parties

2024 | Key management £
At start of period | 92,294
Advances and repayments | 6,271
Interest at 2.25% | 1,898
At end of period | 100,463

2023 | Key management £
At start of period | 14,795
Advances and repayments | 75,797
Interest at 2.00% | 1,702
At end of period | 92,294

Terms of loans to related parties

Loans owed by key management are repayable on demand.